SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-165026
Filing Date
2010-07-23
Accepted
2010-07-23 16:21:55
Documents
11
Period of Report
2010-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 758887
2 SPECIMEN STOCK CERTIFICATE dex41.htm EX-4.1 10624
3 DESCRIPTION OF NON-EMPLOYEE DIRECTOR COMPENSATION dex1025.htm EX-10.25 2194
4 CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM dex231.htm EX-23.1 2037
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 7310
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 6938
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3798
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 4127
9 GRAPHIC g12877ex4_1pg1.jpg GRAPHIC 324628
10 GRAPHIC g12877ex4_1pg2.jpg GRAPHIC 121267
11 GRAPHIC g12877g58m73.jpg GRAPHIC 7858
  Complete submission text file 0001193125-10-165026.txt   1423304
Mailing Address 2530 MERIDIAN PARKWAY SUITE 3084 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 3084 DURHAM NC 27713 919-806-4414
OXYGEN BIOTHERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1109
Type: 10-K | Act: 34 | File No.: 001-34600 | Film No.: 10967639
SIC: 8731 Services-Commercial Physical & Biological Research